Reference number : 172-2024-2025-Q4-1028318, amendment number : , agreement type : C, recipient legal name : HDAX Therapeutics Inc., recipient country : CA, recipient province : ON, recipient city : Toronto|Toronto, recipient postal code : M5H 2R2, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : The characterization of novel HDAC6 inhibitors and assessment of therapeutic impact, agreement title french : La caractérisation de nouveaux inhibiteurs de HDAC6 et l’évaluation de l’impact thérapeutique, agreement number : 1028318, agreement value : 75000.0, agreement start date : 2025-03-01, agreement end date : 2026-03-27, description english : The characterization of novel HDAC6 inhibitors and assessment of therapeutic impact., description french : La caractérisation de nouveaux inhibiteurs de HDAC6 et l’évaluation de l’impact thérapeutique., expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada